LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Comparison of Human and Mouse Interleukins Reveals Link

By LabMedica International staff writers
Posted on 05 Feb 2019
Image: Modified human interleukin-27-alpha. Inspired by the murine interleukin-27-alpha, one amino acid has been exchanged, enabling the formation of a disulfide-bridge (marked in red) (Photo courtesy of Dr. M. Feige, Technical University of Munich).
Image: Modified human interleukin-27-alpha. Inspired by the murine interleukin-27-alpha, one amino acid has been exchanged, enabling the formation of a disulfide-bridge (marked in red) (Photo courtesy of Dr. M. Feige, Technical University of Munich).
A study comparing the structure and function of human and mouse interleukins revealed a close link between protein folding and immune regulation.

Interleukins are small, secreted proteins that drive immune cell communication. Understanding how cells produce interleukins is considered to be critical for decoding and modulating immune responses. An example of particular complexity and biological relevance is the interleukin 12 (IL-12) family. Four functionally distinct alpha-beta heterodimers are assembled from only five subunits to regulate immune cell function and development. In addition, some subunits act as independent signaling molecules. In particular, IL-27 is composed of two subunits, alpha and beta. In humans, these have to assemble to form bioactive IL-27, whereas in mice, IL-27alpha can be secreted alone, modulating immune reactions and reducing sepsis-related mortality.

Investigators at the Technical University of Munich (Germany) reported in the January 16, 2019, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America that differences in a single amino acid determined if IL-27alpha could be secreted autonomously, acting as a signaling molecule, or if it depended on hetero-dimerization for secretion.

By combining computer simulations with biochemical experiments, the investigators dissected the underlying structural determinants: a protein folding switch coupled to disulfide bond formation regulated chaperone-mediated retention versus secretion.

Using these insights the investigators changed folding and assembly control for this protein. This provided the basis for a more human-like IL-27 system in mice and established a secretion-competent human IL-27alpha that signaled on its own and could regulate immune cell function.

"The interleukins are the vocabulary with which immune cells communicate," explained Dr. Matthias Feige, professor of cellular protein biochemistry at the Technical University of Munich. "The cells form these messenger molecules according to a very specific blueprint of individual amino acids. Their arrangement determines, which three-dimensional structure an interleukin adopts and, consequently, which information it transmits. Our approach allowed us to rationally extend the language of immune cells by engineering a key signaling molecule. This provides us with an opportunity to modulate the reaction of immune cells in a targeted manner."

Related Links:
Technical University of Munich

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
8-Channel Pipette
SAPPHIRE 20–300 µL

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more